Susan C. Ross

Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.

Marie Boyd, Susan C. Ross, Jennifer Dorrens et al. · PubMed · 2006 · 146 citations

[131I]<i>meta</i>-Iodobenzylguanidine and Topotecan Combination Treatment of Tumors Expressing the Noradrenaline Transporter

A. McCluskey, Marie Boyd, Susan C. Ross et al. · Clinical Cancer Research · 2005 · 65 citations · Full text

An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation‐mediated bystander effects

Marie Boyd, Robert J. Mairs, W. Nicol Keith et al. · The Journal of Gene Medicine · 2004 · 55 citations

Transfectant mosaic spheroids: a new model for evaluation of tumour cell killing in targeted radiotherapy and experimental gene therapy

Marie Boyd, S. C. Mairs, Karen Stevenson et al. · The Journal of Gene Medicine · 2002 · 40 citations

Preclinical Evaluation of no-Carrier-Added [131I]Meta-Iodobenzyl Guanidine, for the Treatment of Tumours Transfected with the Noradrenaline Transporter Gene

Marie Boyd, Susan C. Ross, Julie A. Owens et al. · Letters in Drug Design & Discovery · 2004 · 14 citations